Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. uri icon

authors

  • Strong, Randy
  • Dudley Lamming, PhD
  • Javors, Martin A
  • de Magalhães, João Pedro
  • Martinez, Paul Anthony
  • McCord, Joe M
  • Miller, Benjamin F
  • Müller, Michael
  • Nelson, James F
  • Ndukum, Juliet
  • Rainger, G Ed
  • Miller, Richard A
  • Richardson, Arlan
  • Sabatini, David M
  • Salmon, Adam B
  • Simpkins, James W
  • Steegenga, Wilma T
  • Nadon, Nancy L
  • Harrison, David E
  • Antebi, Adam
  • Astle, Clinton M
  • Bogue, Molly
  • Denzel, Martin S
  • Fernandez, Elizabeth
  • Flurkey, Kevin
  • Hamilton, Karyn L

publication date

  • January 1, 2016